P2Y12 Inhibitors in STEMI Patients — One Size Does Not Fit All

Saved in:

Bibliographic Details
Published in:	Cardiovascular drugs and therapy Vol. 38; no. 1; pp. 5 - 7
Main Authors:	Patel, Rajiv C., Jones, Jeffrey E., Stouffer, George A.
Format:	Journal Article
Language:	English
Published:	New York Springer US 01-02-2024 Springer Nature B.V
Subjects:	Cardiology Clopidogrel Humans Invited Editorial Medicine Medicine & Public Health Percutaneous Coronary Intervention - adverse effects Platelet Aggregation Inhibitors Prasugrel Hydrochloride Purinergic P2Y Receptor Antagonists - adverse effects ST Elevation Myocardial Infarction - diagnosis ST Elevation Myocardial Infarction - drug therapy Treatment Outcome
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Author	Jones, Jeffrey E. Stouffer, George A. Patel, Rajiv C.
Author_xml	– sequence: 1 givenname: Rajiv C. surname: Patel fullname: Patel, Rajiv C. organization: Division of Cardiology and the McAllister Heart Institute, University of North Carolina – sequence: 2 givenname: Jeffrey E. surname: Jones fullname: Jones, Jeffrey E. organization: Division of Cardiology and the McAllister Heart Institute, University of North Carolina – sequence: 3 givenname: George A. orcidid: 0000-0001-8208-8998 surname: Stouffer fullname: Stouffer, George A. email: rick_stouffer@med.unc.edu organization: Division of Cardiology and the McAllister Heart Institute, University of North Carolina
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/37530947$$D View this record in MEDLINE/PubMed
BookMark	eNp9kLtOAzEQRS0URELgByiQJRqahfErXndEgUCkQJCAgsraeCewaOOF9aaAio_gC_kSHMJDoqCaYs69MzqbpOUrj4TsMDhgAPowMFBKJ8BFAloanfA10mFKi0RzyVqkA4ZDIjj02mQzhAeIIWPSDdIWWgkwUnfI0SW_ZZyO_H0xLZqqDrTw9Or65HxEL7OmQN8E-v76Rice6VXxgvS4wkAvqoYOi4b2y3KLrM-yMuD21-ySm-HJ9eAsGU9OR4P-OHFCQ5PImZNumkrHlEl7DkHpHB0yw7RI89woyERmsJcKpRnkThshjFAiNfmM4RREl-yveh_r6mmBobHzIjgsy8xjtQiWp1JFH8Is0b0_6EO1qH38znITOdmTSkWKryhXVyHUOLOPdTHP6mfLwC792pVfG_3aT7-Wx9DuV_ViOsf8J_ItNAJiBYS48ndY_97-p_YDB4qDvA
Cites_doi	10.1016/j.jacc.2016.03.513 10.1016/j.jacc.2014.08.056 10.1177/1074248418812167 10.1016/j.jacc.2011.09.030 10.1016/j.jacc.2010.02.031 10.1016/j.jacc.2016.02.045 10.1016/j.jcin.2017.07.022 10.1160/TH16-07-0569 10.1016/j.jacc.2013.07.110 10.1161/ATVBAHA.118.311963 10.1093/eurheartj/ehaa575 10.1016/j.jacc.2011.04.017 10.1093/eurheartj/ehx393 10.1016/j.jacc.2012.02.026 10.1001/jama.2011.290 10.1056/NEJMoa1209979 10.1016/j.jacc.2013.01.024 10.1001/jama.2010.1543 10.1093/eurheartj/ehab724.2996
ContentType	Journal Article
Copyright	The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023 The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023.
Copyright_xml	– notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023 – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023.
DBID	CGR CUY CVF ECM EIF NPM AAYXX CITATION 8FD FR3 K9. M7Z P64 7X8
DOI	10.1007/s10557-023-07497-2
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Biochemistry Abstracts 1 Biotechnology and BioEngineering Abstracts MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Biochemistry Abstracts 1 ProQuest Health & Medical Complete (Alumni) Engineering Research Database Technology Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic
Database_xml	– sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine Pharmacy, Therapeutics, & Pharmacology
EISSN	1573-7241
EndPage	7
ExternalDocumentID	10_1007_s10557_023_07497_2 37530947
Genre	Editorial Commentary
GrantInformation_xml	– fundername: NIA NIH HHS grantid: T35 AG038047
GroupedDBID	--- -53 -5E -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 1N0 1SB 2.D 203 28- 29B 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67Z 6NX 7X7 88E 8AO 8FI 8FJ 8FW 8UJ 95- 95. 95~ 96X AAAVM AABHQ AABYN AAFGU AAHNG AAIAL AAJKR AAKAS AAKSU AANXM AANZL AARHV AARTL AATNV AATVU AAUYE AAWCG AAYFA AAYIU AAYQN AAYTO ABBBX ABBXA ABDZT ABECU ABFGW ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKAS ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBMV ACBRV ACBXY ACBYP ACGFS ACHSB ACHXU ACIGE ACIPQ ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACTTH ACUDM ACVWB ACWMK ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADKNI ADKPE ADMDM ADOXG ADRFC ADTPH ADURQ ADYFF ADZCM ADZKW AEBTG AEEQQ AEFIE AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFAFS AFEXP AFKRA AFLOW AFNRJ AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGBP AGGDS AGJBK AGKHE AGMZJ AGQEE AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJZVZ AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH L7B LAK LLZTM LSO M1P M4Y MA- N2Q NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RRX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WH7 WJK WK8 YFH YLTOR Z45 Z7U Z82 Z87 Z8O Z8V Z91 ZGI ZMTXR ZOVNA ~EX AACDK AAEOY AAJBT AASML AAYZH ABAKF ACDTI AEFQL AEMSY AFBBN AGRTI AIGIU AJOOF ALIPV CGR CUY CVF ECM EIF H13 NPM AAYXX CITATION 8FD FR3 K9. M7Z P64 7X8
ID	FETCH-LOGICAL-c370t-4fc4cb84c15986ce057dece191738dd950a3a9e6835710dc7933935389df1eb03
IEDL.DBID	AEJHL
ISSN	0920-3206
IngestDate	Sat Oct 26 05:17:07 EDT 2024 Thu Oct 10 22:43:48 EDT 2024 Thu Nov 21 22:47:31 EST 2024 Sat Nov 02 12:24:31 EDT 2024 Tue Feb 20 01:14:15 EST 2024
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c370t-4fc4cb84c15986ce057dece191738dd950a3a9e6835710dc7933935389df1eb03
Notes	SourceType-Other Sources-1 content type line 63 ObjectType-Editorial-2 ObjectType-Commentary-1
ORCID	0000-0001-8208-8998
OpenAccessLink	https://link.springer.com/content/pdf/10.1007/s10557-023-07497-2.pdf
PMID	37530947
PQID	2928446455
PQPubID	36270
PageCount	3
ParticipantIDs	proquest_miscellaneous_2845105390 proquest_journals_2928446455 crossref_primary_10_1007_s10557_023_07497_2 pubmed_primary_37530947 springer_journals_10_1007_s10557_023_07497_2
PublicationCentury	2000
PublicationDate	2024-02-01
PublicationDateYYYYMMDD	2024-02-01
PublicationDate_xml	– month: 02 year: 2024 text: 2024-02-01 day: 01
PublicationDecade	2020
PublicationPlace	New York
PublicationPlace_xml	– name: New York – name: United States – name: Dordrecht
PublicationTitle	Cardiovascular drugs and therapy
PublicationTitleAbbrev	Cardiovasc Drugs Ther
PublicationTitleAlternate	Cardiovasc Drugs Ther
PublicationYear	2024
Publisher	Springer US Springer Nature B.V
Publisher_xml	– name: Springer US – name: Springer Nature B.V
References	Rollini, Franchi, Hu (CR10) 2016; 67 Collet, Cuisset, Range (CR18) 2012; 367 Alexopoulos, Xanthopoulou, Gkizas (CR6) 2012; 5 Trenk, Stone, Gawaz (CR17) 2012; 59 Allencherril, Alam, Levine (CR20) 2019; 24 Parodi, Valenti, Bellandi (CR7) 2013; 61 Price, Berger, Teirstein (CR16) 2011; 305 Collet, Thiele, Barbato (CR2) 2021; 42 Das, Alexander, Chen (CR12) 2011; 58 Ibanez, James, Agewall (CR1) 2017; 39 Cavallari, Lee, Beitelshees (CR13) 2018; 11 Levine, Bates, Bittl (CR3) 2016; 68 Hochholzer, Trenk, Fromm (CR9) 2010; 55 Perl, Lerman-Shivek, Rechavia (CR4) 2014; 63 CR11 Klein, Williams, Lee, Stouffer (CR14) 2019; 39 Flierl, Zauner, Sieweke (CR5) 2017; 26 Mega, Simon, Collet (CR15) 2010; 304 Bonello, Pansieri, Mancini (CR8) 2011; 58 Parodi, Xanthopoulou, Bellandi (CR19) 2015; 65 G Parodi (7497_CR19) 2015; 65 L Perl (7497_CR4) 2014; 63 JL Mega (7497_CR15) 2010; 304 JP Collet (7497_CR18) 2012; 367 LH Cavallari (7497_CR13) 2018; 11 D Alexopoulos (7497_CR6) 2012; 5 F Rollini (7497_CR10) 2016; 67 GN Levine (7497_CR3) 2016; 68 W Hochholzer (7497_CR9) 2010; 55 U Flierl (7497_CR5) 2017; 26 MJ Price (7497_CR16) 2011; 305 D Trenk (7497_CR17) 2012; 59 SR Das (7497_CR12) 2011; 58 J Allencherril (7497_CR20) 2019; 24 J-P Collet (7497_CR2) 2021; 42 7497_CR11 MD Klein (7497_CR14) 2019; 39 B Ibanez (7497_CR1) 2017; 39 L Bonello (7497_CR8) 2011; 58 G Parodi (7497_CR7) 2013; 61
References_xml	– volume: 68 start-page: 1082 issue: 10 year: 2016 end-page: 115 ident: CR3 article-title: 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2016.03.513 contributor: fullname: Bittl – volume: 5 start-page: 797 issue: 6 year: 2012 end-page: 804 ident: CR6 article-title: Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment–elevation myocardial infarction publication-title: Circ: Cardiovasc Interv contributor: fullname: Gkizas – volume: 65 start-page: 511 issue: 5 year: 2015 end-page: 512 ident: CR19 article-title: Ticagrelor crushed tablets administration in STEMI patients: the MOJITO study publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2014.08.056 contributor: fullname: Bellandi – volume: 24 start-page: 215 issue: 3 year: 2019 end-page: 224 ident: CR20 article-title: Do we need potent intravenous antiplatelet inhibition at the time of reperfusion during ST-segment elevation myocardial infarction? publication-title: J Cardiovasc Pharmacol Ther doi: 10.1177/1074248418812167 contributor: fullname: Levine – volume: 58 start-page: 2642 issue: 25 year: 2011 end-page: 2650 ident: CR12 article-title: Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-segment elevation myocardial infarction: results from the NCDR (National Cardiovascular Data Registry) publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2011.09.030 contributor: fullname: Chen – volume: 55 start-page: 2427 issue: 22 year: 2010 end-page: 2434 ident: CR9 article-title: Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2010.02.031 contributor: fullname: Fromm – volume: 67 start-page: 1994 issue: 17 year: 2016 end-page: 2004 ident: CR10 article-title: Crushed prasugrel tablets in patients with STEMI undergoing primary percutaneous coronary intervention: the CRUSH study publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2016.02.045 contributor: fullname: Hu – volume: 11 start-page: 181 issue: 2 year: 2018 end-page: 191 ident: CR13 article-title: Multisite investigation of outcomes with implementation of CYP2C19 genotype-guided antiplatelet therapy after percutaneous coronary intervention publication-title: JACC Cardiovasc Interv doi: 10.1016/j.jcin.2017.07.022 contributor: fullname: Beitelshees – volume: 26 start-page: 99 issue: 01 year: 2017 end-page: 104 ident: CR5 article-title: Efficacy of prasugrel administration immediately after percutaneous coronary intervention in ST-elevation myocardial infarction publication-title: Thromb Haemost doi: 10.1160/TH16-07-0569 contributor: fullname: Sieweke – volume: 63 start-page: 513 issue: 6 year: 2014 end-page: 517 ident: CR4 article-title: Response to prasugrel and levels of circulating reticulated platelets in patients with ST-segment elevation myocardial infarction publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2013.07.110 contributor: fullname: Rechavia – volume: 39 start-page: 647 issue: 4 year: 2019 end-page: 652 ident: CR14 article-title: Clinical utility of CYP2C19 genotyping to guide antiplatelet therapy in patients with an acute coronary syndrome or undergoing percutaneous coronary intervention publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.118.311963 contributor: fullname: Stouffer – volume: 42 start-page: 1289 issue: 14 year: 2021 end-page: 1367 ident: CR2 article-title: 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) publication-title: Eur Heart J doi: 10.1093/eurheartj/ehaa575 contributor: fullname: Barbato – volume: 58 start-page: 467 issue: 5 year: 2011 end-page: 473 ident: CR8 article-title: High on-treatment platelet reactivity after prasugrel loading dose and cardiovascular events after percutaneous coronary intervention in acute coronary syndromes publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2011.04.017 contributor: fullname: Mancini – ident: CR11 – volume: 39 start-page: 119 issue: 2 year: 2017 end-page: 177 ident: CR1 article-title: 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) publication-title: Eur Heart J doi: 10.1093/eurheartj/ehx393 contributor: fullname: Agewall – volume: 59 start-page: 2159 issue: 24 year: 2012 end-page: 2164 ident: CR17 article-title: A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2012.02.026 contributor: fullname: Gawaz – volume: 305 start-page: 1097 issue: 11 year: 2011 end-page: 1105 ident: CR16 article-title: Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial publication-title: JAMA doi: 10.1001/jama.2011.290 contributor: fullname: Teirstein – volume: 367 start-page: 2100 issue: 22 year: 2012 end-page: 2109 ident: CR18 article-title: Bedside monitoring to adjust antiplatelet therapy for coronary stenting publication-title: N Engl J Med doi: 10.1056/NEJMoa1209979 contributor: fullname: Range – volume: 61 start-page: 1601 issue: 15 year: 2013 end-page: 1606 ident: CR7 article-title: Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2013.01.024 contributor: fullname: Bellandi – volume: 304 start-page: 1821 issue: 16 year: 2010 end-page: 1830 ident: CR15 article-title: Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis publication-title: JAMA doi: 10.1001/jama.2010.1543 contributor: fullname: Collet – ident: 7497_CR11 doi: 10.1093/eurheartj/ehab724.2996 – volume: 59 start-page: 2159 issue: 24 year: 2012 ident: 7497_CR17 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2012.02.026 contributor: fullname: D Trenk – volume: 58 start-page: 467 issue: 5 year: 2011 ident: 7497_CR8 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2011.04.017 contributor: fullname: L Bonello – volume: 11 start-page: 181 issue: 2 year: 2018 ident: 7497_CR13 publication-title: JACC Cardiovasc Interv doi: 10.1016/j.jcin.2017.07.022 contributor: fullname: LH Cavallari – volume: 305 start-page: 1097 issue: 11 year: 2011 ident: 7497_CR16 publication-title: JAMA doi: 10.1001/jama.2011.290 contributor: fullname: MJ Price – volume: 65 start-page: 511 issue: 5 year: 2015 ident: 7497_CR19 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2014.08.056 contributor: fullname: G Parodi – volume: 5 start-page: 797 issue: 6 year: 2012 ident: 7497_CR6 publication-title: Circ: Cardiovasc Interv contributor: fullname: D Alexopoulos – volume: 55 start-page: 2427 issue: 22 year: 2010 ident: 7497_CR9 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2010.02.031 contributor: fullname: W Hochholzer – volume: 39 start-page: 119 issue: 2 year: 2017 ident: 7497_CR1 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehx393 contributor: fullname: B Ibanez – volume: 63 start-page: 513 issue: 6 year: 2014 ident: 7497_CR4 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2013.07.110 contributor: fullname: L Perl – volume: 39 start-page: 647 issue: 4 year: 2019 ident: 7497_CR14 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.118.311963 contributor: fullname: MD Klein – volume: 61 start-page: 1601 issue: 15 year: 2013 ident: 7497_CR7 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2013.01.024 contributor: fullname: G Parodi – volume: 67 start-page: 1994 issue: 17 year: 2016 ident: 7497_CR10 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2016.02.045 contributor: fullname: F Rollini – volume: 58 start-page: 2642 issue: 25 year: 2011 ident: 7497_CR12 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2011.09.030 contributor: fullname: SR Das – volume: 367 start-page: 2100 issue: 22 year: 2012 ident: 7497_CR18 publication-title: N Engl J Med doi: 10.1056/NEJMoa1209979 contributor: fullname: JP Collet – volume: 42 start-page: 1289 issue: 14 year: 2021 ident: 7497_CR2 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehaa575 contributor: fullname: J-P Collet – volume: 24 start-page: 215 issue: 3 year: 2019 ident: 7497_CR20 publication-title: J Cardiovasc Pharmacol Ther doi: 10.1177/1074248418812167 contributor: fullname: J Allencherril – volume: 68 start-page: 1082 issue: 10 year: 2016 ident: 7497_CR3 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2016.03.513 contributor: fullname: GN Levine – volume: 26 start-page: 99 issue: 01 year: 2017 ident: 7497_CR5 publication-title: Thromb Haemost doi: 10.1160/TH16-07-0569 contributor: fullname: U Flierl – volume: 304 start-page: 1821 issue: 16 year: 2010 ident: 7497_CR15 publication-title: JAMA doi: 10.1001/jama.2010.1543 contributor: fullname: JL Mega
SSID	ssj0007998
Score	2.4116018
SourceID	proquest crossref pubmed springer
SourceType	Aggregation Database Index Database Publisher
StartPage	5
SubjectTerms	Cardiology Clopidogrel Humans Invited Editorial Medicine Medicine & Public Health Percutaneous Coronary Intervention - adverse effects Platelet Aggregation Inhibitors Prasugrel Hydrochloride Purinergic P2Y Receptor Antagonists - adverse effects ST Elevation Myocardial Infarction - diagnosis ST Elevation Myocardial Infarction - drug therapy Treatment Outcome
Title	P2Y12 Inhibitors in STEMI Patients — One Size Does Not Fit All
URI	https://link.springer.com/article/10.1007/s10557-023-07497-2 https://www.ncbi.nlm.nih.gov/pubmed/37530947 https://www.proquest.com/docview/2928446455 https://search.proquest.com/docview/2845105390
Volume	38
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDLZgSIgL70dhoCAhLiyoTZ-5McGmgXhM2pDgVDVNKipQh-h2gBM_gl_IL8FZuw0EHODcKI3sxP4cx58B9hIVRWj2IhrYiadvqxjlzFJUiVgKzxSM-bp2uNXxL2-Ck4amybHHVxfZ_eEoIzk01J9q3VzXp-hiKHo97lO0uzPoe1zc3DP1xlnrfGyAfT5sgWtyXRzMTK-slfl5lq_-6BvI_JYgHfqd5sK_VrwI8yXMJPViXyzBlMqWYfaiTKQvw367oKx-rpHupAIrr5F90p6QWT-vwFGb3VqMnGZ3qUh1Zx6SZqTTRe2RdkHJmpP31zdylSnSSV8UOempnFz2-qSZ9kn94WEVrpuN7nGLll0XaGz7Zp86SezEInBiS1O3xwoBnVSx0nGdHUjJXTOyI648hG6ITmSMB1yX9yLwkYmlhGmvQSXrZWoDCAaLnMnEDXzBHSsRIvGUZUUSMYTnJNIy4GAk-_CxINcIJzTKWnohSi8cSi9kBlRH6gnLg5aHjKN_1dlZ14Dd8Wc8IjrvEWWqN8AxgaNhpM1NA9YLtY5_Z2O4hhGub0BtpMTJ5L-vZfNvw7dgjiEYKl57V6HSfxqobZjO5WCn3LwfCmDkEw
link.rule.ids	315,782,786,27933,27934,41073,42142,48344,48347,49649,49652,52153
linkProvider	Springer Nature
linkToHtml	http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwEB5BkRYuwLI8wmPXSCsuW0uJ8_SNilIVLZRK7Ur0FMWxIyKhFJH2ACd-BL-QX8I4jxbEcoBzrMSasWe-yfj7DPA7UVGEYS-igZ14-m8Vo5xZiioRS-GZgjFfc4e7A793FbRPtUyOU3NhitPudUuyiNSvyG6u61PMMRTTHvcpBt4lrXbOGrDUuhqN2rMI7PPiDlyTa3YwM72KLPP_t7xNSO9Q5rsOaZF4Omtfm_I6rFZAk7TKlfEdFlS2Ad8uqlb6Bhz1S9Hq-yYZzjlYeZMckf5czvr-Bxz32chi5Cy7TkWq7-YhaUYGQ_Qf6ZeirDl5fnwil5kig_RBkfZY5aQ3npBOOiGtm5tN-Nc5HZ50aXXvAo1t35xQJ4mdWARObGnx9lghpJMqVrqyswMpuWtGdsSVh-AN8YmMcYtrgi9CH5lYSpj2FjSycaZ2gGC5yJlM3MAX3LESIRJPWVYkEUV4TiItA_7Uxg9vS3mNcC6krK0XovXCwnohM2C_9k9YbbU8ZBwzrO7PugYczh7jJtGdjyhT4ymOCRwNJG1uGrBd-nX2ORsLNqxxfQOatRPnL_94LrufG_4LlrvDi_Pw_Kz3dw9WGEKj8uz3PjQmd1N1AIu5nP6sVvILKG3oRQ
linkToPdf	http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB7xkBCXtrzalJeREJeuReI8feuqu6ulhW2kXSQ4RXFsq5FQFjXZAz31R_QX8ks63mR3QcABcY5lW56x55uMv88Ax1qlKR57KY1cHZi_VYxy5iiqRCZFYAvGQsMd7g_DwVXU6RqZnDmLf3rbfVaSrDkNRqWpqE5vpT59QHzz_ZBivKEYAnlI8RBe9TCTQU9fbXe_98_np3HIp-_h2twwhZkdNMSZ53t5HJyeIM4n1dJpEOq9f_v0P8C7BoCSdu0xG7Ckik1Yu2hK7JtwEtdi1nctMlpws8oWOSHxQub6bgu-xuzaYeSs-JWL3LzZQ_KCDEdoVxLXYq0luf_7j_wsFBnmfxTpjFVJBuOK9PKKtG9utuGy1x1969PmPQaauaFdUU9nXiYiL3OMqHumEOpJlSmT8bmRlNy3UzflKkBQh7hFZrj1DfEXIZHUjhK2uwMrxbhQn4BgGsmZ1H4UCu45WggdKMdJJaKLwNPSseDLzBDJbS27kSwEls3qJbh6yXT1EmbB3sxWSbMFy4RxjLymbutbcDT_jJvHVETSQo0n2CbyDMB0uW3Bx9rG8-FcTOQw9w0taM0Muuj85bl8fl3zQ1iLO73k_GzwYxfWGSKm-kr4HqxUvydqH5ZLOTlonPo_N0nwxg
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=P2Y12+Inhibitors+in+STEMI+Patients+%E2%80%94+One+Size+Does+Not+Fit+All&rft.jtitle=Cardiovascular+drugs+and+therapy&rft.au=Patel%2C+Rajiv+C.&rft.au=Jones%2C+Jeffrey+E.&rft.au=Stouffer%2C+George+A.&rft.date=2024-02-01&rft.pub=Springer+US&rft.issn=0920-3206&rft.eissn=1573-7241&rft.volume=38&rft.issue=1&rft.spage=5&rft.epage=7&rft_id=info:doi/10.1007%2Fs10557-023-07497-2&rft.externalDocID=10_1007_s10557_023_07497_2
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0920-3206&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0920-3206&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0920-3206&client=summon